SEMAGLUTIDE : ONE THOROUGH REVIEW

The emerging class of GLP-1 receptor and GIP dual medications, including tirzepatide, semaglutide, and the newly introduced retatrutide, offer groundbreaking advances in diabetes management . Although all three work by modulating sugar levels , they vary in their particular mechanisms of performa